Abstract

Vancomycin is one of the most important and commonly used antibiotics in hospitals. Despite numerous investigations, however, it is not clear how vancomycin recognizes its site of action in the bacterial cell wall. The increasing incidence of bacterial resistance to vancomycin makes it imperative to understand these recognition determinants so that alternative agents may be developed. Herein we report the first crystal structure of vancomycin. The structure resolves a long-standing controversy about carboxylate recognition by vancomycin, suggests a possible cooperative mechanism linking ligand binding and dimerization, and demonstrates the operation of a novel intramolecular flap which occupies the binding site in the absence of ligand.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.